{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:05:48Z","timestamp":1792112748352,"version":"4.4.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,17]],"date-time":"2017-11-17T00:00:00Z","timestamp":1510876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ejca.2017.11.003","type":"journal-article","created":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T18:54:36Z","timestamp":1513104876000},"page":"102-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["No overdiagnosis in the Norwegian Breast Cancer Screening Program estimated by combining record linkage and questionnaire information in the Norwegian Women and Cancer study"],"prefix":"10.1016","volume":"89","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8071-8711","authenticated-orcid":false,"given":"Eiliv","family":"Lund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelie","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Thalabard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2017.11.003_bib1","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1056\/NEJMp1401875","article-title":"Abolishing mammography screening programs? A view from the Swiss Medical Board","volume":"370","author":"Biller-Andorno","year":"2014","journal-title":"NEJM"},{"key":"10.1016\/j.ejca.2017.11.003_bib2","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/S0140-6736(12)61611-0","article-title":"Independent UKPBCS: the benefits and harms of breast cancer screening: an independent review","volume":"380","author":"Marmot","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2017.11.003_bib3","series-title":"Screening for breast cancer with mammography","author":"Goetzsche","year":"2013"},{"key":"10.1016\/j.ejca.2017.11.003_bib4","first-page":"1159","article-title":"European breast cancer service screening outcomes: a first balance sheet of the benefits and harms","volume":"23","author":"Paci","year":"2014","journal-title":"CEBP"},{"key":"10.1016\/j.ejca.2017.11.003_bib5","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1056\/NEJMsr1504363","article-title":"Breast cancer screening \u2013 viewpoint of the IARC Working Group","volume":"372","author":"Lauby-Secretan","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2017.11.003_bib6","unstructured":"The Research Council of Norway. www.forskningsradet.no\/publikasjoner Research-based evaluation of the Norwegian Breast Cancer Screening Program. Final report."},{"issue":"9","key":"10.1016\/j.ejca.2017.11.003_bib7","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1001\/jamainternmed.2015.3043","article-title":"Breast cancer screening, incidence, and mortality across US counties","volume":"175","author":"Harding","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"15","key":"10.1016\/j.ejca.2017.11.003_bib8","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.2015.13183","article-title":"Benefits and harms of breast cancer screening: a systematic review","volume":"314","author":"Myers","year":"2015","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ejca.2017.11.003_bib9","doi-asserted-by":"crossref","first-page":"256","DOI":"10.7326\/M15-0970","article-title":"Harms of breast cancer screening: systematic review to update the 2009 U.S. Preventive services task force recommendation","volume":"164","author":"Nelson","year":"2016","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.ejca.2017.11.003_bib10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/gme.0b013e3181ea1fd5","article-title":"Type of hormone therapy and risk of misclassification at mammography screening","volume":"18","author":"Njor","year":"2011","journal-title":"Menopause"},{"key":"10.1016\/j.ejca.2017.11.003_bib11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10549-013-2540-z","article-title":"Survival of patients with BRCA1-associated breast cancer diagnosed in an MRI-based surveillance program","volume":"139","author":"Moller","year":"2013","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ejca.2017.11.003_bib12","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.molonc.2013.07.005","article-title":"Progression from ductal carcinoma in situ to invasive breast cancer: revisited","volume":"7","author":"Cowell","year":"2013","journal-title":"Mol Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2017.11.003_bib13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/ije\/dym137","article-title":"Cohort profile: the Norwegian women and cancer study \u2013 NOWAC \u2013 Kvinner og kreft","volume":"37","author":"Lund","year":"2008","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ejca.2017.11.003_bib14","series-title":"Cancer in Norway 2011-Cancer incidence, mortality, survival and prevalence in Norway","author":"Cancer Registry of Norway","year":"2013"},{"key":"10.1016\/j.ejca.2017.11.003_bib15","series-title":"Cancer registration: principles and methods","author":"Jensen","year":"1991"},{"key":"10.1016\/j.ejca.2017.11.003_bib16","first-page":"1001","article-title":"External validity in a population-based national prospective study \u2013 the Norwegian Women and Cancer Study (NOWAC)","volume":"10","author":"Lund","year":"2003","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ejca.2017.11.003_bib17","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.3109\/0284186X.2011.599339","article-title":"Mammography activity in Norway 1983 to 2008","volume":"50","author":"Lynge","year":"2011","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejca.2017.11.003_bib18","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1136\/bmj.38044.666157.63","article-title":"Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study","author":"Zahl","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.ejca.2017.11.003_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2587","article-title":"Overdiagnosis in publicly organized mammography screening programmes: systematic review of incidence trends","volume":"339","author":"J\u00f8rgensen","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ejca.2017.11.003_bib20","doi-asserted-by":"crossref","first-page":"491","DOI":"10.7326\/0003-4819-156-7-201204030-00005","article-title":"Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian Screening program","volume":"156","author":"Kalager","year":"2012","journal-title":"Ann Int Med"},{"key":"10.1016\/j.ejca.2017.11.003_bib21","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1186\/1471-2407-13-614","article-title":"Overdiagnosis of breast cancer in the Norwegian breast Cancer Screening Program estimated by the Norwegian Women and Cancer cohort study","volume":"13","author":"Lund","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejca.2017.11.003_bib22","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ijc.28052","article-title":"Overdiagnosis among women attending a population-based mammography screening program","volume":"133","author":"Falk","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2017.11.003_bib23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/0969141316668379","article-title":"Breast cancer incidence trends in Norway and estimates of overdiagnosis","volume":"24","author":"Van Luijt","year":"2017","journal-title":"J Med Screen"},{"key":"10.1016\/j.ejca.2017.11.003_bib24","first-page":"111","article-title":"Interpreting overdiagnosis estimates in population-based mammography screening","volume":"33","author":"De Gelder","year":"2011","journal-title":"Epi Rev"},{"issue":"Suppl. 1","key":"10.1016\/j.ejca.2017.11.003_bib25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1258\/jms.2012.012082","article-title":"Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review","volume":"19","author":"Pulit","year":"2012","journal-title":"J Med Screen"},{"issue":"9","key":"10.1016\/j.ejca.2017.11.003_bib26","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S1470-2045(15)00128-X","article-title":"Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial","volume":"16","author":"Moss","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2017.11.003_bib27","unstructured":"http:\/\/www.gradeworkinggroup.org\/."},{"key":"10.1016\/j.ejca.2017.11.003_bib28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejca.2017.04.018","article-title":"Overdiagnosis in breast cancer screening: the impact of study design and calculations","volume":"80","author":"Lynge","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2017.11.003_bib29","series-title":"Editorial. Numero thematique \u2013 depistage organize du cancer de sein","year":"2012"},{"key":"10.1016\/j.ejca.2017.11.003_bib30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1258\/jms.2008.007071","article-title":"Estimating mean sojourn time and screening sensitivity using questionnaire data on time since previous screening","volume":"15","author":"Weedon-Fekj\u00e6r","year":"2008","journal-title":"J Med Screen"},{"issue":"9","key":"10.1016\/j.ejca.2017.11.003_bib31","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/jnci\/djq099","article-title":"Overdiagnosis in cancer","volume":"102","author":"Welch","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2017.11.003_bib32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1470-2045(15)00446-5","article-title":"Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study","volume":"17","author":"Duffy","year":"2016","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2017.11.003_bib33","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1148\/radiol.14131502","article-title":"Mammographic performance in a population-based screening program: before, during, and after the transition from screen-film to full-field digital mammography","volume":"272","author":"Hofvind","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.ejca.2017.11.003_bib34","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ijc.20389","article-title":"Hormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian Women and Cancer study","volume":"112","author":"Bakken","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2017.11.003_bib35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10549-013-2830-5","article-title":"Mammographic screening detects low-risk tumor biology breast cancers","volume":"144","author":"Drukker","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejca.2017.11.003_bib36","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/ijc.29030","article-title":"Peripheral blood cells inform on the presence of breast cancer: a population-based case-control study","volume":"136","author":"Dumeaux","year":"2015","journal-title":"Int J Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804917314004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804917314004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T08:49:14Z","timestamp":1660121354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804917314004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":36,"alternative-id":["S0959804917314004"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2017.11.003","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No overdiagnosis in the Norwegian Breast Cancer Screening Program estimated by combining record linkage and questionnaire information in the Norwegian Women and Cancer study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2017.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}